Molecular targets and gene therapy of lung cancer
Lung cancer is of great interest in human pathology because its apparent aggressiveness cannot be stopped by applied treatment procedures. The lack of highly specific screening tests prevents an early diagnosis of the disease. Insidious beginning and diverse and unclear clinical picture are responsi...
Main Author: | Vasić Ljiljana |
---|---|
Format: | Article |
Language: | English |
Published: |
Institute of Oncology, Sremska Kamenica, Serbia
2009-01-01
|
Series: | Archive of Oncology |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0354-7310/2009/0354-73100902019V.pdf |
Similar Items
-
Translational Benefits of Gene Therapy to Date
by: M Mary McMenamin
Published: (2011-03-01) -
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
by: Adjei, A.A, et al.
Published: (2022) -
Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review
by: Beate Aurich, et al.
Published: (2021-05-01) -
Protecting intellectual property associated with Canadian academic clinical trials - approaches and impact
by: Ross Sue, et al.
Published: (2012-12-01) -
A Randomized Trial of Liposomal Paclitaxel plus Cisplatin as First-line Therapy for Advanced Non-small Cell Lung Cancer
by: Xi LI, et al.
Published: (2012-04-01)